Search Within

Computational Oncology Service

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (239)
  3. Editorial (8)
  4. Review (8)
  5. Book Section (1)
  6. Conference Paper (1)
  7. Research Letter (1)
Groups
  1. Epidemiology and Biostatistics (640)
  2. Human Oncology and Pathogenesis Program (640)
  3. GSK Faculty (639)
  4. Department of Medicine (470)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (465)
  6. Solid Tumor Oncology Division (411)

More Groups

People
  1. Nikolaus Schultz (486)
  2. Michael Berger (177)
  3. David Solit (165)
  4. Jianjiong Gao (110)
  5. Marc Ladanyi (98)
  6. Francisco Sanchez Vega (91)

More People

Years
  1. 2025 (21)
  2. 2024 (47)
  3. 2023 (53)
  4. 2022 (76)
  5. 2021 (49)
  6. 2020 (75)

More Years

Publications
  1. Journal of Clinical Oncology (98)
  2. Cancer Research (66)
  3. Clinical Cancer Research (46)
  4. Nature Communications (27)
  5. Blood (26)
  6. Nature (26)

More Publications

Publishers
  1. American Association for Cancer Research (144)
  2. American Society of Clinical Oncology (115)
  3. Nature Publishing Group (97)
  4. Oxford University Press (39)
  5. Cell Press (37)
  6. American Society of Hematology (30)

More Publishers

Results (640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • A novel approach to quantify heterogeneity of intrahepatic cholangiocarcinoma: The hidden-genome classifier
    Journal Article

    Song, Y.; Boerner, T.; Drill, E.; Shin, P.; Kumar, S.; Sigel, C.; Cercek, A.; Kemeny, N.; Abou-Alfa, G.; Iacobuzio-Donahue, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • PAK4-targeted PROTACs in clear cell renal cell carcinoma: A two-for-one targeted and immune therapy?
    Editorial

    Bakouny, Z.; Braun, D. A.; Reznik, E.; Hakimi, A. A.
    EBioMedicine (2024)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of acquired resistance and treatment duration for targeted therapies in colorectal cancer
    Journal Article

    Harrold, E.; Keane, F.; Walch, H.; Chou, J. F.; Sinopoli, J.; Palladino, S.; Al-Rawi, D. H.; Chadalavada, K.; Manca, P.; Chalasani, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Deep-learning model for tumor-type prediction using targeted clinical genomic sequencing data
    Journal Article

    Darmofal, M.; Suman, S.; Atwal, G.; Toomey, M.; Chen, J. F.; Chang, J. C.; Vakiani, E.; Varghese, A. M.; Balakrishnan Rema, A.; Syed, A.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series
    Journal Article

    Anselmino, N.; Labanca, E.; Shepherd, P. D. A.; Dong, J.; Yang, J.; Song, X.; Nandakumar, S.; Kundra, R.; Lee, C.; Schultz, N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Artificial intelligence in oncology: Current landscape, challenges, and future directions
    Review

    Lotter, W.; Hassett, M. J.; Schultz, N.; Kehl, K. L.; Van Allen, E. M.; Cerami, E.
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • The NF-I/a transcription factor is a HIF-independent oncogenic dependency in kidney cancer
    Meeting Abstract

    Scovell, J.; Zayas, S.; Grubb, T.; Kuo, F.; Reznik, E.; Hakimi, A. A.; Chakraborty, A.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save